Octreotide and hepatocellular carcinoma

Br J Cancer. 2007 Jun 4;96(11):1778-9. doi: 10.1038/sj.bjc.6603799. Epub 2007 May 15.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / pathology
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / pathology
  • Male
  • Octreotide / adverse effects
  • Octreotide / therapeutic use*
  • Receptors, Somatostatin / antagonists & inhibitors
  • Receptors, Somatostatin / metabolism

Substances

  • Antineoplastic Agents, Hormonal
  • Receptors, Somatostatin
  • Octreotide